Abstract
purpose. To examine the response of mouse retina to sustained hyperoxia. Hyperoxia is toxic to photoreceptors after sustained exposure (7–14 days in the C57BL/6J mouse) but has been reported to enhance photoreceptor function after short-term exposure.
methods. Retinas from the hyperoxia-vulnerable C57BL/6J mouse and from the hyperoxia-resistant BALB/cJ mouse were examined after 0, 3, 7, 14, and 35 days’ exposure to 75% oxygen. Quantitative PCR, TUNEL, and immunohistochemical techniques were used to trace the regulation and site of expression of the early-response, potentially protective gene Oxr1.
results. In the C57BL/6J retina, Oxr1 was upregulated at 3 days of exposure, matching the early period of resistance to hyperoxia in this strain, and fell below control levels at 14 days, when photoreceptor degeneration had begun. By contrast, the stress-related gene GFAP was upregulated only at 7 to 14 days. Immunohistochemistry showed a concentration of Oxr1 in the inner part of photoreceptor outer segments, but, as photoreceptors underwent apoptosis, Oxr1 concentrated in the nucleus, confirming earlier reports that photoreceptors were resistant to hyperoxia until 14 days in the BALB/cJ mouse and, correspondingly, that the upregulation of Oxr1 in outer segments was sustained until 14 days.
conclusions. The patterns of Oxr1 expression observed suggest that the gene is associated with resistance to hyperoxic challenge and that it acts at the level of the outer segment. The retinal response to hyperoxia may constitute acute and chronic phases in which photoreceptors are first resistant, and then vulnerable, to oxidative damage. Understanding this biphasic response may be important in understanding the role of oxygen in the progress of retinal dystrophy.
The normal adult retina is vulnerable to damage by environment-related stress, even in conditions that are environmentally normal. Examples of this normal-environment vulnerability include the hyperoxia-related erosion of the anterior edge of the retina,
1 2 the depletion of the photoreceptor layer associated with increases in daily ambient light,
3 the vulnerability of photoreceptors to light during the night phase of the normal daily cycle (Organisciak D, et al.
IOVS 1998;39:ARVO Abstract 4571),
4 and the progressive loss of retinal sensitivity in the last decades of human life, associated with the loss of rods throughout life.
5 6 One factor contributing to this vulnerability is the absence of autoregulation of the choroidal circulation, which delivers oxygen to photoreceptors. Any factor that decreases the consumption of oxygen by photoreceptors, including light adaptation
7 or the depletion of the photoreceptor population by disease
8 9 or age,
10 causes a sustained rise in oxygen tension in the outer retina. Rises in retinal oxygen sustained over days and weeks are known to be specifically toxic to photoreceptors
11 12 13 14 15 and may contribute to the progressive degeneration of the retina seen in advanced age or in the later stages of retinal dystrophy.
10
However, the effect of hyperoxia on the retina is not simply toxic. Earlier reports provide evidence that relatively short periods of hyperoxia (hours rather than days) can enhance the rodent electroretinogram (ERG).
16 In humans, hyperbaric oxygen therapy, which involves repeated, brief (2-hour) episodes of intense hyperoxia, can enhance the ERG and significantly slow retinal dystrophy.
17 18 We have, therefore, examined the response of the C57BL/6J mouse retina to hyperoxia, in which photoreceptor death begins with a delay of 7 to 14 days,
13 14 15 to test whether significant regulation of gene expression could be detected before the onset of photoreceptor death. That is, we sought to establish the basis for the acute enhancing and chronically toxic effects of hyperoxia on retinal function.
We report that in the C57BL/6J mouse retina, the expression of the mouse homologue (C7)
19 of the human protective (oxidation-resistant) gene
Oxr1 20 goes through a biphasic course, first upregulated when photoreceptors are resistant to hyperoxia and later downregulated as photoreceptors succumb.
Oxr1 has been shown to be involved in free radical scavenging of hydrogen peroxide, with the protein located in the mitochondria of human cells,
21 and in the nucleoli
19 of human, mouse, and rat cell lines. It seems possible that
Oxr1, acting as a free radical scavenger, plays a protective role in the early stages of hyperoxia-induced death of photoreceptors.
Animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Mice (C57BL/6J, BALB/cJ) were raised in dim (5 lux) cyclic illumination (12 hours light/12 hours dark). These levels of lighting were maintained during exposure to hyperoxia. Three-month-old adult mice (C57BL/6J, BALB/cJ) were placed in a clear acrylic plastic chamber and exposed to an atmosphere of 75% oxygen for 0 (control), 3, 7, 14, or 35 days. Oxygen levels were maintained using a controlled feedback device (Oxycycler; Biospherix, Lacona, NY).
After fixation, eyes were cryoprotected in 30% sucrose overnight. Eyes were embedded (Tissue-Tek; Sakura Finetek, Torrance, CA), snap frozen in liquid nitrogen, cryosectioned at 14 μm, mounted on gelatinized poly-L-lysine–coated glass slides, stored at −20°C, and used for immunohistochemistry and TUNEL procedures.
Tissue from six retinas was pooled, and RNA was extracted using reagent (Trizol; Invitrogen, Carlsbad, CA) and RNA purification (RNAqueous-Micro kit; Ambion, Austin, TX). Genomic DNA was removed using DNase treatment according to the purification kit (RNAqueous-Micro kit; Ambion) protocol. Quality control of RNA was performed using the 2100 Bioanalyzer; Agilent, Palo Alto, CA), and only RNA with an RNA integrity number greater than 9.0 was used. Retinal mouse RNA was used as the template with the qRT-PCR system (Superscript III Platinum One-Step; Invitrogen) according to the standard protocol. A region of mouse Oxr1 was amplified using forward 5′-CAG GGA GTG GGA GGT AGT GT-3′ and reverse 5′-ATG GTT CTT GGT GGA AGG TG-3′ primers. Mouse GFAP was amplified using forward 5′-TCCTGGAACAGCAAAACAAG-3′ and reverse 5′-CAGCCTCAGGTTGGTTTCAT-3′ primers (The Harvard NeuroDiscovery Center: http://www.neurodiscovery.harvard.edu/). GAPDH was used as a control gene and was amplified using forward 5′-TGAAGCAGGCATCTGAGGG-3′ and reverse 5′-CGAAGGTGGAAGAGTGGGAG-3′ primers (RT-Database: http://medgen.ugent.be/rtprimerdb/).
Real-time PCR was performed using a real-time system (Rotorgene 3000; Corbett Research, Sydney, Australia) and appropriate software (Rotor-Gene 6; Corbett Research). Analysis for discovery of fold change was performed using the Pfaffl method
22 with GAPDH primers as control primers and no oxygen treatment as control. Relative fold change was expressed as a percentage fold change relative to control (0 days) and normalized to a control gene (
GAPDH).
For miocroarray (GeneChip; Affymetrix, Santa Clara, CA) analysis, RNA was processed, labeled, and hybridized to a mouse genome 430 2.0 array (GeneChip; Affymetrix) according to the standard protocol. This work was performed at the John Curtin School of Medical Research (Biomolecular Resource Facility; http://brf.jcs.anu.edu.au/index.htm). Analysis was performed using GCOS V1.4, and sorting for robust changes was performed according to the Affymetrix guidelines (www.affymetrix.com). Comparisons were performed with RNA extracted from control age-matched animals (no hyperoxia) to animals exposed to hyperoxia for 3, 7, and 14 days. Experiments were performed with biological replicates. Only genes with a significance of P < 0.05 were considered in this study.
Images for optical densitometry were collected using an inverted fluorescence microscope (Axiovert 200; Carl Zeiss, Thornwood, NY) and a digital camera (AxioCam MRc5; Carl Zeiss). During the acquisition of images from animals in different treatment groups, the gain, contrast, and color balance of the scanning system were held constant. Images were converted to gray scale and were analyzed for densitometry using ImageJ (developed by Wayne Rasband, National Institutes of Health, Bethesda, MD; available at http://rsb.info.nih.gov/ij/index.html).
Previous studies have identified
Oxr1 as localized to nucleoli in mouse tissue
19 and to mitochondria in yeast.
20 21 Elliott and Volkert
21 stressed that the anti-oxidant activity for which they screened in identifying the gene required
Oxr1 to be located in mitochondria. Therefore, we anticipated that the protein Oxr1 would be located principally in mitochondria, and immunolabeling localized intense labeling to the junction of inner and outer segments, close to where mitochondria concentrate in the outer part of the inner segment. At higher power, however, peak immunolabeling for Oxr1 appeared localized to the inner part of the outer segments, which does not contain mitochondria, and to be separate from mitochondria in the inner segment. Further, we could not locate Oxr1 in the mitochondria prominent at the other end of the photoreceptor, in the axon terminal.
30 Our results do not, however, preclude the presence of lower levels of Oxr1 in the mitochondria inner segment.
Late in the process of photoreceptor degeneration in our model, Oxr1 was differently located, in the nuclei of photoreceptors in the ONL. This nuclear labeling occurred only in regions of retina in which photoreceptors were dying; in many instances, Oxr1 and TUNEL labeling colocalized. In such areas, Oxr1 antibodies labeled all TUNEL+ nuclei and additional nuclei that were not TUNEL+. This suggests that the nuclei may become Oxr1+ before their nuclear DNA fragments, attracting the TUNEL label. This nuclear location of Oxr1 in the nuclei of cells undergoing apoptosis has not previously been noted, and its functional significance is unknown.
This late movement of Oxr1 to the nuclei of dying cells indicates that the protein can move within the cell. The observation
21 that Oxr1 is localized to mitochondria was made in cultured cells after short exposures (hours); it is possible that localization changed by the third time point, which we monitored.